Combination of Conservative and Interventional Therapy Strategies for Intra- and Extrahepatic Cholangiocellular Carcinoma: A Retrospective Survival Analysis

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left">Therapy</td><td align="center">Total (<i>n</i>)</td><td align="center">Median survival (months)</td><td align="center">significance (<i>P</i>)</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Chemo + PDT</td><td align="center">11</td><td align="center">16.3 (10.9)</td><td align="center"></td></tr><tr><td align="left">Chemo</td><td align="center">84</td><td align="center">14.5 (16.9)</td><td align="center">.283</td></tr><tr><td align="left">Chemo + TACE</td><td align="center">14</td><td align="center">22.0 (10)</td><td align="center"></td></tr><tr><td align="left">Chemo</td><td align="center">81</td><td align="center">12.2(16.6)</td><td align="center">.039</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Median 3-year-survival (IQR) of patients with cholangiocarcinoma undergoing stand-alone chemotherapy versus combination of chemotherapy and interventional therapies (palliation group).

Gastroenterology Research and Practice

tab3

Table 3

Table 3: Combination of Conservative and Interventional Therapy Strategies for Intra- and Extrahepatic Cholangiocellular Carcinoma: A Retrospective Survival Analysis 

Table 3 | Combination of Conservative and Interventional Therapy Strategies for Intra- and Extrahepatic Cholangiocellular Carcinoma: A Retrospective Survival Analysis 